nocodazole has been researched along with African Lymphoma in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inverse relation of apoptosis and polyploidy induction by paclitaxel or nocodazole in BL." | 3.81 | Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma. ( Chumduri, C; Daniel, PT; Gillissen, B; Milojkovic, A; Müller, A; Overkamp, T; Pott, C; Richter, A, 2015) |
| "Ilmofosine treated CA46 cells failed to accumulate hyperphosphorylated-cdc2/cyclin B1 complexes that are observed when G2-arrest is induced by either nitrogen mustard or ionizing radiation." | 1.29 | The protein kinase C inhibitor ilmofosine (BM 41 440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents. ( Grunicke, H; Hofmann, J; Jackman, J; Kohn, KW; O'Connor, PM; Schubert, C; Ueberall, F, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chumduri, C | 1 |
| Gillissen, B | 1 |
| Richter, A | 2 |
| Milojkovic, A | 1 |
| Overkamp, T | 1 |
| Müller, A | 1 |
| Pott, C | 1 |
| Daniel, PT | 1 |
| Leao, M | 1 |
| Anderton, E | 2 |
| Wade, M | 1 |
| Meekings, K | 1 |
| Allday, MJ | 2 |
| Yee, J | 1 |
| Smith, P | 1 |
| Crook, T | 1 |
| White, RE | 1 |
| O'Connor, PM | 3 |
| Ferris, DK | 1 |
| Hoffmann, I | 1 |
| Jackman, J | 2 |
| Draetta, G | 1 |
| Kohn, KW | 3 |
| Fan, S | 1 |
| el-Deiry, WS | 1 |
| Bae, I | 1 |
| Freeman, J | 1 |
| Jondle, D | 1 |
| Bhatia, K | 1 |
| Fornace, AJ | 1 |
| Magrath, I | 1 |
| Hofmann, J | 1 |
| Schubert, C | 1 |
| Ueberall, F | 1 |
| Grunicke, H | 1 |
| Cherney, BW | 1 |
| Bhatia, KG | 1 |
| Sgadari, C | 1 |
| Gutierrez, MI | 1 |
| Mostowski, H | 1 |
| Pike, SE | 1 |
| Gupta, G | 1 |
| Magrath, IT | 1 |
| Tosato, G | 1 |
| Domina, AM | 1 |
| Smith, JH | 1 |
| Craig, RW | 1 |
8 other studies available for nocodazole and African Lymphoma
| Article | Year |
|---|---|
Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma.
Topics: Animals; Apoptosis; Burkitt Lymphoma; Caspase Inhibitors; Caspases; Cell Line; DNA Fragmentation; Fl | 2015 |
Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.
Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Burkitt Lymphoma; Cell | 2007 |
Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.
Topics: Antigens, Viral; Antineoplastic Agents; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Burkit | 2008 |
Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard.
Topics: Aphidicolin; Burkitt Lymphoma; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle Proteins; Cell Li | 1994 |
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Topics: Apoptosis; Burkitt Lymphoma; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Topoisom | 1994 |
The protein kinase C inhibitor ilmofosine (BM 41 440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents.
Topics: Alkaloids; Antineoplastic Agents; Burkitt Lymphoma; CDC2 Protein Kinase; Cell Cycle; Cell Line; DNA | 1994 |
Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells.
Topics: Animals; Biopsy; Burkitt Lymphoma; Cell Cycle; Female; Genes, p53; Humans; Mice; Mice, Inbred BALB C | 1997 |
Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition.
Topics: Burkitt Lymphoma; Cell Cycle; Cell Survival; Enzyme Activation; Enzyme Inhibitors; G2 Phase; Humans; | 2000 |